ALZpath retweeted
🚨What if Alzheimer’s could be detected years - even decades - before symptoms begin? 🧠
That future is closer than most people realize. 🚀
On the latest episode of @ProgressPotent1 I sat down with Mike Banville, CEO of @AlZpath
After decades scaling global businesses, Mike is now focused on one of healthcare’s biggest challenges:
👉Making early, accessible Alzheimer’s detection a reality.
We explore:
• How ALZpath’s pTau217 antibody is enabling blood tests that may rival PET scans and spinal taps;
• Why earlier detection could reshape clinical trials, treatment timing, and patient outcomes;
• The bigger shift toward precision medicine and proactive brain health;
This isn’t just about diagnostics - it’s about changing when the fight against Alzheimer’s begins. ⚕️
#Alzheimers #BrainHealth #Biotech #EarlyDetection #PrecisionMedicine #HealthcareInnovation #Dementia #Neuroscience #Longevity @FINNPartners @FPIPR @SiemensHealth @Roche @RocheDiaUSA @BCILifeSciences @BeckmanDx
ALZpath retweeted
@Roche received CE Mark approval for the Elecsys pTau217 blood test, developed with @EliLillyandCo & powered by ADDF-funded @AlZpath’s pTau217 antibody. The approval marks another important step toward broader access to scalable Alzheimer’s diagnostics. reut.rs/4dBdopf
ALZpath retweeted
Bold move aims to scale blood-based diagnostics globally as demand for earlier, more accessible Alzheimer’s disease detection accelerates
longevity.technology/news/ne…
#longevity #Alzheimers #AlzheimersTesting #BloodTest #EarlyDetection #Neurodegeneration #HealthTech #MedTech
ALZpath retweeted
Pharma & biotech innovation is accelerating in 2025, from needle-free anaphylaxis rescue to AI-boosted newborn screening and blood-based Alzheimer’s diagnostics. The top 15 most innovative pharma & biotech companies of 2025, taken from Fast Company’s list, are redefining discovery, delivery and patient impact.
📊 Explore our infographic to see who’s leading and why:
• ARS Pharma (@ars_pharma)
• Bristol Myers Squibb (@bmsnews)
• Eli Lilly (@EliLillyandCo)
• Aurion Biotech (@AurionBiotech)
• Iovance Biotherapeutics (@IovanceBio)
• Adaptimmune (@Adaptimmune)
• Verona Pharma (@VeronaPharma)
• Pfizer (@pfizer)
• ImmunityBio (@ImmunityBio)
• Zevra Therapeutics (@zevratx)
• ALZpath (@AlZpath)
• GeneDX (@GeneDx)
• 10x Genomics (@10xGenomics)
• Protagonist Therapeutics (@ProtagonistTx)
• Recursion (@RecursionPharma)
👉 Read more here: buff.ly/3akY1uy
#Pharma #Biotech #Innovation #DrugDiscovery #ClinicalTrials #RareDisease #Oncology #Respiratory #Alzheimers #Genomics
ALZpath retweeted
79% of scientists and researchers recently polled believe that p-tau 217 holds the most promise for advancing early detection of AD in the next 5 years.
Learn how we're advancing AD pathology detection with the Simoa® ALZpath p-Tau217 Assay: quanterix.com/advancing-alzh…
ALZpath retweeted
AAIC25: ALZpath’s pTau217 advances role in Alzheimer’s disease R&D
ALZpath’s pTau217 antibody was released in 2023 and continues to be a key focus in Alzheimer’s disease research and development.
medicaldevice-network.com/ne…
ALZpath retweeted
Thank you to the more than 11,700 researchers, clinicians and dementia professionals who joined us in Toronto and online for #AAIC25!
Together, you advanced science and clinical practice and have given hope to all those living with Alzheimer’s and all other dementia.
ALZpath retweeted
#Global #Momentum and #Validation #Grows at #AAIC for #ALZpath #Proprietary pTau217 #Antibody #Use in #Alzheimer's #Disease #Research, #Diagnosis, and #Treatment tinyurl.com/38pjbc4x @AlZpath
ALZpath retweeted
🗣🎙We also had an interview today with Mike Banville, of @AlZpath, who highlighted the company's presentations on its pTau217 antibody at #AAIC25! 🇨🇦 📹 @alzassociation
ALZpath retweeted
Research affirms high diagnostic accuracy of blood test for Alzheimer’s
ALZpath’s pTau217 test could be as accurate as invasive spinal tap, new study suggests.
#diagnostics #research #bloodtest #alzheimers #pTau217
longevity.technology/news/re…
ALZpath retweeted
Congratulations to ALZpath - Best Invention of 2024 Award for their #Alzheimers p-tau217 blood test!
Patients and physicians benefit as #AlzheimersDisease can be diagnosed more simply. We partnered with ALZpath to use their p-tau217 test in our recent Phase 2 AD Trial.
ALZpath retweeted
In this episode, hear from Dr. Lee Honigberg, VP of Research & Development, ALZpath, a provider of diagnostic tools for Alzheimer’s disease. Listen now at buff.ly/4gW23ji 🎙️
ALZpath retweeted
🌟MEET OUR FINALISTS🌟
ADVANCEMENTS IN NEUROLOGICAL TREATMENTS
🔹ALZpath pTau217 Antibody - @AlZpath
🔹BrainProbe - @NYCU_official
🔹VORANIGO® (vorasidenib tablets) - @Servier
#EdisonAwards #HealthTech #Biotech #PatientOutcomes #Innovation
ALZpath retweeted
Congratulations to our partners @Alzpath, one of the Diagnostics Accelerator portfolio companies recognized as one of @FastCompany's Most Innovative Biotech Companies of 2025! Their blood test is revolutionizing Alzheimer's care and research.
bit.ly/4bIcRR4
ALZpath retweeted
Innovation drives the field forward. Great to see @FastCompany recognize the innovation and technology @Alzpath, one of the Diagnostics Accelerator portfolio companies as one of the Most Innovative Biotech Companies of 2025!
Congratulations to our partners @Alzpath, one of the Diagnostics Accelerator portfolio companies recognized as one of @FastCompany's Most Innovative Biotech Companies of 2025! Their blood test is revolutionizing Alzheimer's care and research.
bit.ly/4bIcRR4
ALZpath retweeted
#ALZpath #Announces #New #Funding from the #Alzheimer's #Drug #Discovery #Foundation (#ADDF) to #Advance a #Novel, #Diagnostic #Blood-Based #Assay rb.gy/sz2j1 @AlZpath
ALZpath retweeted
June is Alzheimer’s & Brain Awareness Month. 💜 RETWEET to raise awareness in honor of all those impacted by Alzheimer’s and other dementia. Together, we will #ENDALZ.
ALZpath retweeted
At the Alzheimer's Association, diversity, equity and inclusion are vital to our mission. This month, we’re celebrating Alzheimer’s & Brain Awareness Month and #PrideMonth. 🌈🏳️⚧️ Thank you to all of our LGBTQ+ champions in the fight to #ENDALZ!
ALZpath retweeted
June is Alzheimer’s & Brain Awareness Month! #GoPurple to raise awareness in honor of the more than 6 million Americans living with Alzheimer’s. Learn more: alz.org/abam. #ENDALZ
ALZpath retweeted
Please re-Tweet if you agree: Good #caregiving focuses on what people living with #Alzheimers disease or other forms of #dementia can do (rather than what they cannot). Offer encouragement, build confidence, share love.
#happiness #kindness #quote
